Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Rating) – HC Wainwright dropped their FY2025 EPS estimates for shares of Actinium Pharmaceuticals in a report released on Monday, April 3rd. HC Wainwright analyst J. Pantginis now forecasts that the biotechnology company will earn $1.34 per share for the year, down from their previous forecast of $1.49. HC […]
StockNews.com downgraded shares of Actinium Pharmaceuticals (NYSEAMERICAN:ATNM – Get Rating) from a hold rating to a sell rating in a report released on Friday morning. A number of other analysts have also weighed in on the stock. William Blair lowered shares of Actinium Pharmaceuticals from an outperform rating to a market perform rating in a […]